Syndax Pharmaceuticals (SNDX)
(Delayed Data from NSDQ)
$20.11 USD
-0.59 (-2.85%)
Updated Jun 14, 2024 04:00 PM ET
After-Market: $20.07 -0.04 (-0.20%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth B Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/01/2024
Time: -- |
6/2024 | $-0.92 | 6.18% |
Earnings Summary
For their last quarter, Syndax Pharmaceuticals (SNDX) reported earnings of -$0.85 per share, beating the Zacks Consensus Estimate of $-0.96 per share. This reflects a positive earnings surprise of 11.46%. Look out for SNDX's next earnings release expected on August 01, 2024. For the next earning release, we expect the company to report earnings of -$0.92 per share, reflecting a year-over-year decrease of 43.75%.
Earnings History
Price & Consensus
Zacks News for SNDX
Syndax (SNDX) Gets FDA Priority Tag for Leukemia Drug NDA
SNDX: What are Zacks experts saying now?
Zacks Private Portfolio Services